Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 620 clinical trials
Liquid Biopsies for Improving the Pre-operative Diagnosis of Ovarian Cancer

(CA125 and HE4) to differentiate between early ovarian cancer and benign ovarian tumors pre-operatively. Nature and extent of the burden and risks associated with participation, benefit and group

tumor cells
cancer antigen 125
cancer of the ovary
  • 0 views
  • 31 Jul, 2021
  • 4 locations
Thymidine Kinase 1 in Risk Assessment for Hereditary Breast /Ovarian Cancer

This study aimed to compare the activity of Thymidine Kinase 1 in serum of two groups of woman at high and normal risk for breast/ovary cancer.

breast cancer
combinations
cancer of the ovary
  • 8 views
  • 07 Nov, 2020
  • 1 location
Prehabilitation Care for Women With Advanced Ovarian Cancer Receiving Neoadjuvant Chemotherapy

The purpose of this study is evaluate whether a prehabilitation program is feasible and useful for women with advanced ovarian cancer receiving chemotherapy in preparation for debulking surgery

ovarian epithelial carcinoma
cancer
carcinoma
peritoneal carcinoma
primary peritoneal carcinoma
  • 0 views
  • 19 Mar, 2021
  • 1 location
Multi-Centre Observational Study of Maintenance Niraparib in Treatment of Ovarian CanceR

This is a multi-centre, observational (non-interventional) study, designed to follow patients with advanced ovarian fallopian tube and primary peritoneal cancer, who are receiving Niraparib as maintenance treatment, according to the Niraparib access criteria (via TESARO patient access programme, EMA licence and NHS pending NICE assessment due 2018) including assessment of …

primary peritoneal carcinoma
fallopian tube
ovarian cancer
cancer
niraparib
  • 3 views
  • 26 Jan, 2021
  • 7 locations
The Role of Cytomegalovirus and Inflammation on Patient Symptoms and Outcomes in Ovarian Cancer

research idea for this study, supported by previous preliminary data, is that CMV reactivation is an unrecognized complicating factor in the treatment of ovarian cancer that impacts patient outcomes. The

cancer of the ovary
fallopian tube
ovarian cancer
cancer
cancer treatment
  • 8 views
  • 19 Sep, 2021
  • 1 location
Minimally Invasive Robotic Surgery Role in Optimal Debulking Ovarian Cancer Recovery & Survival

MIRRORS "Minimally Invasive Robotic Surgery, Role in Optimal Debulking Ovarian Cancer, Recovery & Survival" is a new United Kingdom based prospective feasibility study the purpose of which

fallopian tube
cancer
immunological adjuvant
fallopian tube cancer
cancer chemotherapy
  • 7 views
  • 26 Jan, 2021
  • 1 location
Tumor Grade Determines PD-1/PDL-1 Expression

usually more aggressive than type I and is estrogen independent. Type II endometrial cancer is usually characterized as high grade while type I as low intermediate and high grade. Ovarian carcinoma as

tumor cells
ovarian epithelial carcinoma
cancer
carcinoma
endometrial carcinoma
  • 0 views
  • 25 Jan, 2021
  • 1 location
Analysis of Tumors From Patients With Inherited Cancers Having Had Two Surgeries (Primary + Recurrent or 2 Separate Types of Cancer)

This study will analyze tumor tissue from patients with known genetic mutations (BRCA1, BRCA2, CHK2, etc) who have tumor tissue available from two surgeries, either primary/recurrent, or two different anatomical sites.

BRCA2
BRCA1
  • 1 views
  • 18 Jul, 2021
  • 1 location
Ovarium Cancer Detection by TEP's and ctDNA

Rationale: Cancer is primarily diagnosed by clinical presentation, imaging and pathological analysis of tissue biopsies, increasingly supported by molecular diagnostics tests. However, late diagnosis and misdiagnosis due to limitations of tissue biopsy acquisition remains a major problem. Therefore, a general blood test to pinpoint cancer early and adequately can be …

tumor cells
cancer of the ovary
tumor markers
  • 15 views
  • 23 Jan, 2021
  • 3 locations
Phenotypic Spectrum of CTCs in Tumors of the Female Reproductive System

patients with tumors of the female reproductive system (breast cancer, endometrial cancer, and ovarian cancer). The primary objective are: To assess the presence and number of

  • 0 views
  • 01 Apr, 2021
  • 1 location